Ardhea Jaludamascena
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

ASSOCIATION BETWEEN WORKING EXPERIENCE AND DYSLIPIDEMIA AMONG INDONESIAN SEAFARER Ardhea Jaludamascena; Dwi Retnoningrum
PROSIDING SEMINAR NASIONAL & INTERNASIONAL 2017: Proceeding International Seminar of Occupational Health and Medical Sciences (I-SOCMED) 2017 “
Publisher : Universitas Muhammadiyah Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (253.847 KB)

Abstract

Seafarers were exposed to many occupational hazards, such as accidents, infectious diseases, workrelated stress, environmental stress and chronic diseases. Longer working experience  means more exposed to these occupational hazards. Morbidity and mortality rate from chronic diseases tend to increase among seafarers. Dyslipidemia is one of independent risk factor of cardiovascular disease among seafarer. The aim of this study is to determine association between working experience and dyslipidemia among Indonesian seafarer. A cross sectional study was conducted on 157 Indonesia male seafarers who came to certified health care for their annual health examination from the beginning of January 2017 until the June 2017. The health examination data encompassed seafarer‟s age, height,weight, body mass index and lipid profile were collected. Seafarers were divided into two groups based on their work experience in sea each groups, then, categorized into with and without dyslipidemia subgroup. Dyslipidemia was defined as having two or more serum lipid profile abnormalities. The prevalence of dyslipidemia was 29.9%. Statistic analysis shown that longer working experience (more than 10 years) had more risk to have dyslipidemia about 3.5 times (95% CI = 1.66-7.59). There was association between working experience and dyslipidemia. Keyword : seafarer, dyslipidemia, lipid profile, occupational health
CASE PRESENTATION OF 55-YEAR-OLD MAN WITH ACUTE MYELOID LEUKEMIA AND COVID 19 Novita Fajar Sari; Herniah Asti Wulanjani; Ardhea Jaludamascena; Dwi Retnoningrum
JURNAL KEDOKTERAN DIPONEGORO (DIPONEGORO MEDICAL JOURNAL) Vol 11, No 3 (2022): JURNAL KEDOKTERAN DIPONEGORO (DIPONEGORO MEDICAL JOURNAL)
Publisher : Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14710/dmj.v11i3.33926

Abstract

Background: Acute myeloid leukemia (AML) is a malignancy originating from multipotential hematopoietic cells, which is characterized by clonal proliferation of abnormal blast cells in the bone marrow and failure of normal cell production. Coronavirus disease-19 (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. COVID-19 infection in AML patients will affect laboratory examinations to support the diagnosis of COVID-19 and the patient's prognosis. Case presentation: A 55-year- old man went to the hospital for chemotherapy and diagnosed of acute myelomonocytic leukemia. Patient complains of his gingival bleeding. The results of the routine haematological examination showed pancytopenia and the patient requires blood transfusion before chemotherapy. On the third day of treatment, the patient complained of fever, after several day patient complained cough, and shortness of breath. Physical examination showed pulse 100x/minutes, respiratory rate 26x/minutes, temperature 39.8˚C, crackles of the lungs. RT-PCR examination from nasopharyngeal swab showed a positive SARS-CoV-2. During treatment, the laboratory tests showed pancytopenia, increased D-Dimer, C-reactive protein, ferritin and procalcitonin. After the 42th day of treatment, the patient had clinical improvement, the fifth evaluation swab showed a negative RT-PCR result. Conclusion: AML patients have a higher risk of infection, especially COVID-19 infection. Correct laboratory examinations and treatment will promote a better prognosis. It is necessary to educate leukemic patients so that they always take precautions against infection, especially the prevention of COVID-19.